Alcobra (ADHD)

Add to Watchlists
Create an Alert
14.21 -0.74  -4.95% NASDAQ Apr 15, 5:01PM BATS Real time Currency in USD
View Full Chart
ADHD Price Chart
View All Performance Charts

ADHD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alcobra is up N/A over the last year vs S&P 500 Total Return up 18.46%, Shire up 57.95%, and Questcor Pharmaceuticals up 183.7%.

Get Quote for
Advertisement

Pro Strategies Featuring ADHD

Did Alcobra make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

ADHD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Israel
  • Headquarters State/Province: N/A
  • Incorporation Country: Israel
  • Incorporation State/Province: N/A
  • Current Fiscal Year End: December 31, 2014

Alcobra Ltd is a biopharmaceutical company which engaged in the development and commercialization of its proprietary drug, MG01CI, to treat attention deficit hyperactivity disorder.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ADHD 14.21 -0.74 -4.95% 193.78M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.